Harnessing Microglia and Macrophages for the Treatment of Glioblastoma

Ioanna Prionisti1,2, Léo H Bühler1, Paul R Walker3

  • 1Division of Digestive and Transplantation Surgery, Geneva University Hospitals, Geneva, Switzerland.

Insights

Glioblastoma multiforme (GBM), a severe brain cancer, involves microglia and macrophages in tumor growth. Targeting microglia motility pathways presents a promising new therapeutic strategy for GBM treatment.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cellular Physiology

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor outcomes.
  • Tumor-associated microglia and macrophages are key players in glioma development within the tumor microenvironment.
  • These cells are emerging as critical therapeutic targets for brain cancer.

Purpose of the Study:

  • To review microglia physiology and their role in brain cancer.
  • To discuss current glioblastoma treatments, including radiotherapy.
  • To highlight novel insights into microglia physiology and potential therapeutic pathways.

Main Methods:

  • Literature review of microglia physiology in brain cancer.
  • Analysis of current glioblastoma treatment modalities.
  • Focus on a recently identified pathway regulating microglia process motility.

Main Results:

  • Microglia and macrophages significantly influence glioma development.
  • Understanding microglia physiology offers new therapeutic avenues.
  • A specific pathway controlling microglia motility is identified as a potential target.

Conclusions:

  • Targeting tumor-associated microglia and macrophages is a promising strategy for GBM.
  • The pathway controlling microglia process motility represents a novel therapeutic target for glioblastoma.
  • Further research into microglia-targeting therapies could improve GBM prognosis.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
841
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
743